Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix

This publication has 30 references indexed in Scilit:

• Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis
  Gynecologic Oncology, 2004
• Outcome and Human Epithelial Growth Factor Receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated using bromodeoxyuridine (BrdU) labelling
  Breast Cancer Research, 2004
• Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Roles of mitogen-activated protein kinase and phosphoinositide 3′-kinase in ErbB2/ErbB3 coreceptor-mediated heregulin signaling☆
  Experimental Cell Research, 2003
• Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
  The Journal of Pathology, 2003
• Stress and Radiation-Induced Activation of Multiple Intracellular Signaling Pathways¹
  Radiation Research, 2003
• Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia
  Seminars in Oncology, 2002
• The Epidermal Growth Factor Receptor and Its Inhibition in Cancer Therapy
  Pharmacology & Therapeutics, 1999
• Distinct characteristics of heregulin signals mediated by HER3 or HER4
  Journal of Cellular Physiology, 1997
• Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
  Proceedings of the National Academy of Sciences, 1989